UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000766
Receipt number R000000918
Scientific Title A phase I study to evaluate the effect and recommended dose of 5-FU(rapid infusion and drip infusion)/l-LV therapy for advanced and/or recurrent colon cancer (OGSG 0406)
Date of disclosure of the study information 2007/07/13
Last modified on 2021/11/15 23:03:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase I study to evaluate the effect and recommended dose of 5-FU(rapid infusion and drip infusion)/l-LV therapy for advanced and/or recurrent colon cancer (OGSG 0406)

Acronym

OGSG 0406

Scientific Title

A phase I study to evaluate the effect and recommended dose of 5-FU(rapid infusion and drip infusion)/l-LV therapy for advanced and/or recurrent colon cancer (OGSG 0406)

Scientific Title:Acronym

OGSG 0406

Region

Japan


Condition

Condition

advanced/recurrent colorectal cancer

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

A phase I clincal study is carried out to evaluate the dose limited toxicity, maximum tolerant dose, or recommended dose on 5-FU(rapid and continuous infusion) plus l-LV for advanced or recurrent colon cancer.

Basic objectives2

Others

Basic objectives -Others

DLT,MTD,RD,Feasibility

Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I


Assessment

Primary outcomes

DLT, MTD, RD

Key secondary outcomes

Feasibility


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Agents dose rout day
l-LV 200mg/m2 div(2 hours) day 1
5-FU 400mg/m2 iv(5 min) day 1
5-FU Xmg/m2 civ(46 hours) day 1

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1. histologically proven colon cancer
2. Age: 20-75 yo
3. Performance status: 0-1 (ECOG criteria)
4. without any prior chemotherapy or with longer than 4 weeks of no-therapy period after prior chemotherapy
5. with sufficient bone marrow, renal or hepatic function
Hemoglobin 8.0 g/dl <=
WBC: 4,000 /mm3 <= and =< 12,000/mm3
Neutrocyte: 2,000/mm3=<
Platelet: 100,000/mm3 =<
Total bilirubin: within normal range of each hospital
GOT, GPT: within 2 times of normal limit of each hospital
Creatinin: within normal range
CRP: 2mg/dl =>
BUN: <= 25mg/dl
alb: >=3g/dl
cardiac function: tolereble to the regimen of this study
6. without hepatitis virus infection (HBs Ag, HCV Ab)
7. expected survival period longer than 3 months
8. written informed consent

Key exclusion criteria

1.with severe bone marrow suppression
2.with a severe infection
3.with severe cardiac disease
4.with some other severe diseases
5.under a poor general condition
6.under diarrhea which continues more than three days
7.with double cancers which were treated within recent 5 years except carcinoma in situ.
8.with familial polyposis or hereditary disease
9.under pregnancy or nursing
10.with a history of allergic response to Levoholinate or fluorouracil
11.re-registration to this study
12.doctors' decision not to register

Target sample size

24


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Fukunaga Mutsumi

Organization

Sakai City Hospital

Division name

Dpt.Surgery

Zip code


Address

1-1-1,Minamiyasuicho,Sakai-ku,Sakai, 590-0064

TEL

072-221-1700

Email



Public contact

Name of contact person

1st name
Middle name
Last name Furukawa Hiroshi

Organization

Sakai City Hospital

Division name

Director

Zip code


Address

1-1-1,Minamiyasuicho,Sakai-ku,Sakai, 590-0064

TEL

072-221-1700

Homepage URL


Email



Sponsor or person

Institute

OGSG

Institute

Department

Personal name



Funding Source

Organization

NPO Osaka Chinical Study Supporting Organization

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 07 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2004 Year 09 Month 09 Day

Date of IRB


Anticipated trial start date

2004 Year 10 Month 01 Day

Last follow-up date

2005 Year 10 Month 01 Day

Date of closure to data entry

2005 Year 11 Month 01 Day

Date trial data considered complete

2006 Year 03 Month 01 Day

Date analysis concluded

2007 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 07 Month 06 Day

Last modified on

2021 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000918


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name